October 26, 2017

Precision medicine discussion

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture.

By Doug Campbell

August 17, 2017

Wilkins named to national committee exploring return of research results

Consuelo Wilkins, M.D., MSCI, executive director of the Meharry-Vanderbilt Alliance, has been appointed to a national committee charged with determining how best to return to research participants the results of studies of their blood and other bio-specimens.

By Bill Snyder

July 5, 2016

Vanderbilt establishes innovation center to boost demographic representation in clinical trial enrollment

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.

By Bill Snyder

June 18, 2015

MVA study shows benefits of pharmacy care in diabetes treatment

Underserved patients with sub-optimally controlled type 2 diabetes who were cared for by pharmacists were more adherent to their medication regimen and had better blood sugar control than those who did not have a pharmacist in their care team.

By Matt Schorr

June 19, 2014

Malow, Wilkins enter leadership program

By Craig Boerner

May 22, 2014

Alliance’s Wilkins to take part in academic health leadership program

Consuelo Wilkins, M.D., MSCI, executive director of the Meharry-Vanderbilt Alliance, has been accepted as a Fellow in the 2014-2015 Class of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women.

By Vanderbilt Health News